Prudential Financial’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
VCM
VPM
N
Prudential Financial's ADMA Position: Q1 2026 in Review
Prudential Financial reduced its ADMA Biologics (ADMA) stake by 5.6% in Q1 2026, selling an estimated $289K and leaving 307,050 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1180.
Prudential Financial first reported a position in ADMA in Q3 2020 and has held it in 19 quarters since. The position peaked at $10.4M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.
- Prudential Financial held 307,050 shares of ADMA Biologics worth $2.77M as of Q1 2026.
- Prudential Financial sold 18,300 ADMA Biologics shares in Q1 2026, an estimated $289K.
- ADMA Biologics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1180 holding.
- Prudential Financial first reported a position in ADMA Biologics in Q3 2020 and has held it in 19 quarters since.
- Prudential Financial's ADMA Biologics position peaked at $10.4M in Q3 2024.
- 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.